Advisors Asset Management, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$414,586
-18.4%
6,919
-1.9%
0.01%
-10.0%
Q2 2023$508,377
-2.7%
7,051
-0.7%
0.01%
-9.1%
Q1 2023$522,276
+8.4%
7,100
-1.6%
0.01%
+10.0%
Q4 2022$481,895
-25.6%
7,214
-4.2%
0.01%
-28.6%
Q3 2022$648,000
-8.2%
7,528
-4.8%
0.01%
+7.7%
Q2 2022$706,000
-52.0%
7,909
-39.5%
0.01%
-43.5%
Q1 2022$1,471,000
+5.4%
13,076
+44.7%
0.02%
+15.0%
Q4 2021$1,396,000
+41.7%
9,035
+27.8%
0.02%
+33.3%
Q3 2021$985,000
+4.8%
7,070
-1.4%
0.02%
+7.1%
Q2 2021$940,000
-14.3%
7,168
-0.4%
0.01%
-17.6%
Q1 2021$1,097,000
+50.3%
7,197
-2.0%
0.02%
+41.7%
Q4 2020$730,000
+30.6%
7,342
+25.2%
0.01%
+20.0%
Q3 2020$559,000
+28.5%
5,863
+50.8%
0.01%
+25.0%
Q2 2020$435,000
+73.3%
3,887
+12.6%
0.01%
+33.3%
Q1 2020$251,000
-55.8%
3,451
-36.7%
0.01%
-40.0%
Q4 2019$568,000
-9.6%
5,448
-13.6%
0.01%
-16.7%
Q3 2019$628,000
-39.3%
6,309
-30.4%
0.01%
-36.8%
Q2 2019$1,035,000
-12.2%
9,064
-3.3%
0.02%
-9.5%
Q1 2019$1,179,000
-9.0%
9,375
-1.9%
0.02%
-19.2%
Q4 2018$1,296,000
-45.1%
9,552
+11.0%
0.03%
-33.3%
Q3 2018$2,362,000
+78.1%
8,605
+34.4%
0.04%
+69.6%
Q2 2018$1,326,000
+137.2%
6,402
+74.0%
0.02%
+155.6%
Q1 2018$559,000
+19.7%
3,679
+7.8%
0.01%
+12.5%
Q4 2017$467,000
+42.8%
3,413
+42.0%
0.01%
+60.0%
Q3 2017$327,0002,4040.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders